Implications of renin‐angiotensin‐system blocker discontinuation in acute decompensated heart failure with systolic dysfunction

BACKGROUND: Renin‐angiotensin‐system blockers (RASB) improve clinical outcomes in patients with chronic heart failure with reduced fraction; however, there remains ambiguity whether RASB therapy should be continued during the treatment of acute decompensated heart failure (ADHF). HYPOTHESIS: In comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Darden, Douglas, Drazner, Mark H., Mullens, Wilfried, Dupont, Matthias, Tang, W. H. Wilson, Grodin, Justin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788475/
https://www.ncbi.nlm.nih.gov/pubmed/31498919
http://dx.doi.org/10.1002/clc.23260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788475/
https://www.ncbi.nlm.nih.gov/pubmed/31498919
http://dx.doi.org/10.1002/clc.23260

Ejemplares similares